title: Commentary on ‘propofol versus thiopental sodium for the treatment of refractory status epilepticus—still no answer’.
abstract: This is a commentary on a Cochrane review, published in this issue of EBCH, first published as:Prabhakar H, Bindra A, Singh GP, Kalaivani M. Propofol versus thiopental sodium for the treatment ofrefractory status epilepticus. Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD009202.DOI: 10.1002/14651858.CD009202.pub2.
authors.affiliation: Alberta Children’s Hospital University of Calgary, Faculty of Medicine, Canada. jeffrey.buchhalter@albertahealthservices.ca
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Buchhalter
authors.forename: Antonia
authors.initials: A
authors.lastname: Stang
mesh_terms: D018686:Anesthetics, Intravenous / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D015742:Propofol / Q000008:administration & dosage*; D013226:Status Epilepticus / Q000188:drug therapy*; D013874:Thiopental / Q000008:administration & dosage*
chemical_list: D018686:Anesthetics, Intravenous; D013874:Thiopental; D015742:Propofol